glp 1 shortage ending New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compounding pharmacies to halt semaglutide

That's my

This is a newer active ingredient and lacks the same level of long-term safety data

All prescription weight loss medications in the UK require proper medical assessment by UK-registered prescribers, ongoing monitoring, and integration with dietary modification and physical activity programmes

Non-Stimulating & Natural: Both ingredients offer their profound benefits without relying on stimulants, making this a clean and effective way to support your fitness and weight management goals

We understand that our care is only as accessible as it is affordable

In other words, the lack of vitamin C biosynthesis allows our bodies to know more about our nutritional status and consequently set the proper baseline of HIF1 expression